Literature DB >> 22457917

A public HLA antigen associated with HLA-A9, Aw32, and Bw4.

D D Kostyu1, P Cresswell, D B Amos.   

Abstract

The HLA complex codes for three distinct 44000 dalton molecules associated with beta2 microglobulin--HLA-A, B and C--each with its own multiallelic series of private antigens. The HLA-B molecule is exceptional in that it also carries a diallelic system, Bw4 and Bw6. One of these, Bw4, is often associated with the A-locus specificity A9. This finding has usually been ascribed to linkage disequilibrium between A- and B-locus antigens. We have shown, however, that an epitope called LHe is actually shared by A-locus and B-locus molecules. This epitope is found on all HLA-B molecules bearing the Bw4 determinant and is also found on all HLA-A molecules carrying the A9 (Aw23 and Aw24) or Aw32 specificities. We consider this a "public" HLA antigen; the possible molecular basis for both subtypic and public antigens on a single glycoprotein is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 22457917     DOI: 10.1007/bf01572579

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  23 in total

1.  Y-antigen killing by T cells of women is restricted by HLA.

Authors:  E Goulmy; A Termijtelen; B A Bradley; J J van Rood
Journal:  Nature       Date:  1977-04-07       Impact factor: 49.962

Review 2.  HLA-A, -B and -C antigens, their serology and cross-reaction.

Authors:  V C Joysey; E Wolf
Journal:  Br Med Bull       Date:  1978-09       Impact factor: 4.291

Review 3.  Monoclonal antibodies as tools to analyze the serological and genetic complexities of major transplantation antigens.

Authors:  J C Howard; G W Butcher; G Galfrè; C Milstein; C P Milstein
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

4.  Absorption, elution and blocking studies with the complex antiserum ST.

Authors:  M W Verghese; F E Ward
Journal:  Tissue Antigens       Date:  1978-10

5.  HLA-B specificities and w4, w6 specificities are on the same polypeptide.

Authors:  J Ayres; P Cresswell
Journal:  Eur J Immunol       Date:  1976-11       Impact factor: 5.532

6.  The complexity of the HL-A gene product. II. Possible evidence for a "public" determinant common to the first and second HL-A series.

Authors:  L Legrand; J Dausset
Journal:  Transplantation       Date:  1975-02       Impact factor: 4.939

7.  Target antigens of cell-mediated lympholysis discrimination of HLA subtypes by cytotoxic lymphocytes.

Authors:  M A Robinson; H J Noreen; D B Amos; E J Yunis
Journal:  J Immunol       Date:  1978-10       Impact factor: 5.422

8.  Human cell-mediated cytotoxicity against modified target cells is restricted by HLA.

Authors:  E Dickmeiss; B Soeberg; A Svejgaard
Journal:  Nature       Date:  1977-12-08       Impact factor: 49.962

9.  Allo-antigens and antigenic factors of human leukocytes. A hypothesis.

Authors:  P Ivanyi; J Dausset
Journal:  Vox Sang       Date:  1966 May-Jun       Impact factor: 2.144

10.  HLA-linked genetic control of the specicity of human cytotoxic T-cell responses to influenza virus.

Authors:  S Shaw; W E Biddison
Journal:  J Exp Med       Date:  1979-03-01       Impact factor: 14.307

View more
  9 in total

Review 1.  KIR and HLA under pressure: evidences of coevolution across worldwide populations.

Authors:  Danillo G Augusto; Maria Luiza Petzl-Erler
Journal:  Hum Genet       Date:  2015-06-23       Impact factor: 4.132

2.  A new public antigen shared by all HLA-A locus products except HLA-A23, -A24, -A32, and -A25 is probably influenced by the amino acid residue at position 79 in the alpha 1 domain.

Authors:  L P de Waal; C van der Meer; A R van der Horst; F H van der Velde
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

3.  Serological demonstration of HLA-Bw4/Bw6 epitopes on hybrid molecules between HLA-B35 and HLA-B51.

Authors:  M Sekimata; H Hayashi; S Nakayama; K Kano; M Takiguchi
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Genetic and serological heterogeneity of the supertypic HLA-B locus specificities Bw4 and Bw6.

Authors:  C A Müller; G Engler-Blum; V Gekeler; I Steiert; E Weiss; H Schmidt
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

5.  Quantitative estimation of HLA-A and HLA-B antigens carrying the Bw4 supertypic specificity in human peripheral blood lymphocytes.

Authors:  J Nosek; E Hinzová; J Vorlíćek
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

6.  The monoclonal xenoantibody Q6/64 recognizes a determinant expressed by certain gene products of the A and B loci of the HLA region.

Authors:  V Quaranta; M A Pellegrino; S Ferrone
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

7.  Antigenic determinants of the HLA-B7 molecule; Bw6- and B7-specific determinants are spatially separate.

Authors:  P Parham
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

8.  A xenogeneic monoclonal antibody recognizing specificities controlled by HLA-A and B alleles.

Authors:  P Richiardi; A Amoroso; T Crepaldi; R Ceppellini; M Trucco
Journal:  Immunogenetics       Date:  1981-03-01       Impact factor: 2.846

Review 9.  The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?

Authors:  Danillo G Augusto
Journal:  Front Genet       Date:  2016-06-28       Impact factor: 4.599

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.